SCHEMBL30819103

SCHEMBL30819103

N#CC[C@H](C1CCN(c2cccc(Cl)n2)C1)n1cc(-c2ncnc3[nH]ccc23)cn1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 2/20 1.00
TYRO3 Q06418 2/20 1.00
JAK2 O60674 14/20 0.74
JAK1 P23458 13/20 0.74
JAK3 P52333 3/20 0.67
DAPK3 O43293 2/20 0.67
PAK4 O96013 2/20 0.67
ABL1 P00519 2/20 0.67
RET P07949 2/20 0.67
LTK P29376 2/20 0.67
CSNK1A1 P48729 2/20 0.67
CLK2 P49760 2/20 0.67
TNK2 Q07912 2/20 0.67
ROCK1 Q13464 2/20 0.67
DYRK1A Q13627 2/20 0.67
IKBKE Q14164 2/20 0.67
NTRK3 Q16288 2/20 0.67
NTRK2 Q16620 2/20 0.67
LRRK2 Q5S007 2/20 0.67
TAOK1 Q7L7X3 2/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL860531 1.00 AXL (1.00) AXLTYRO3JAK2JAK1JAK3
SCHEMBL15653497 1.00 AXL (1.00) AXLTYRO3JAK2JAK1JAK3
SCHEMBL15652975 1.00 AXL (1.00) AXLTYRO3JAK2JAK1JAK3
SCHEMBL29379941 1.00 AXL (1.00) AXLTYRO3JAK2JAK1JAK3
SCHEMBL30008920 1.00 AXL (1.00) AXLTYRO3JAK2JAK1JAK3
SCHEMBL860564 0.92 AXL (0.84) AXLTYRO3JAK2JAK1JAK3
SCHEMBL859327 0.89 AXL (0.81) AXLTYRO3JAK2JAK1JAK3
SCHEMBL859535 0.89 AXL (0.80) AXLTYRO3JAK2JAK1JAK3
SCHEMBL13058316 0.89 AXL (0.80) AXLTYRO3JAK2JAK1JAK3
SCHEMBL3765087 0.89 AXL (0.80) AXLTYRO3JAK2JAK1JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120053645-A Dosing regimen for treating PI 3K-related disorders 因赛特公司 2025-05-30 CN disclosed
CN-119258070-A Dosing regimen for treating PI 3K-related disorders 因赛特公司 2025-01-07 CN disclosed
CN-117800973-A Salts of PI3K inhibitors and methods of making the same 因赛特控股公司 2024-04-02 CN disclosed
CN-117777139-A Salts of PI3K inhibitors and methods of making the same 因赛特控股公司 2024-03-29 CN disclosed
CN-117736209-A Salts of PI3K inhibitors and methods of making the same 因赛特控股公司 2024-03-22 CN disclosed